Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

A Phase 2 Prospective Study Evaluating Low-Dose Deferasirox in Patients with Low-Risk Myelodysplastic Syndrome Resistant or Relapsing after Erythropoietin Stimulating Agents (LODEFI)

Blood (2024) 144 (Supplement 1): 1826.

https://doi.org/10.1182/blood-2024-198104

Published: 2024

Journal Articles

Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim

Blood (2022) 140 (Supplement 1): 6847–6849.

https://doi.org/10.1182/blood-2022-156632

Published: 2022

Journal Articles

HLA-Matched Related Hematopoietic Stem Cell Transplantation in Adolescents and Adults with Sickle Cell Disease: Comparison of Myeloablative Versus Non Myeloablative Approaches. Report from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire

Nathalie Dhedin, Florian Chevillon, Martin Castelle, Virginie Lavoipierre, Jean-Hugues Dalle, Loïc Vasseur, Laure Joseph, Florence Beckerich, Nimrod Buchbinder, Tereza Coman, Frederic Garban, Alina Ferster, Nicolas Boissel, Stephanie Nguyen Quoc, Jean-Benoit Arlet, Corinne Pondarré

Blood (2021) 138 (Supplement 1): 909.

https://doi.org/10.1182/blood-2021-147052

Published: 2021

Journal Articles

Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS

Blood (2017) 130 (Supplement 1): 1705.

https://doi.org/10.1182/blood.V130.Suppl_1.1705.1705

Published: 2017

Journal Articles

Prophylactic Extracorporeal Photopheresis for Gvhd Prevention after Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation from Identical Siblings and 10/10 HLA Unrelated Hematopoietic Stem Cells Donors

Mauricette Michallet, MD PhD, Mohamad Sobh, Pharm.M., Aline Praire, MSc, Frederic Garban, MD PhD, Claude Eric Bulabois, MD, Ibrahim Yakoub-Agha, MD PhD, Valerie Coiteux, MD, Remy Dulery, MD, Pierre-Simon Rohrlich, MDPhD, Faezeh Legrand, MD, Laurence Clement, Stephane Morisset, Stat., Giovanna Cannas, MD, Marie Y. Detrait, MD, Fiorenza Barraco, MD, Franck E. Nicolini, MD PhD, Olivier Hequet, MD

Blood (2014) 124 (21): 3916.

https://doi.org/10.1182/blood.V124.21.3916.3916

Published: 2014

Journal Articles

Reduced Intensity Conditioning Regimens Do Not Offer a Survival Advantage to Myeloma Patients Receiving Allogeneic Stem Cell Hematopoietic Transplantation: A Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry Study,

Yvan Beaussant, Etienne Daguindau, MD, Aurore Vivot, Mohamad Mothy, MD, PhD, Herve Avet-Loiseau, MD, PhD, Damien Roos-Weil, MD, Mauricette Michallet, Nicole Raus, Didier Blaise, MD, Stephane Vigouroux, MD, Agnes Buzyn, MD, PhD, Gérard Socié, Nathalie Fegueux, Frederic Garban, MD, PhD, Eric Deconinck, MD, PhD

Blood (2011) 118 (21): 4113.

https://doi.org/10.1182/blood.V118.21.4113.4113

Published: 2011

Journal Articles

Disease Status Is the Major Prognosis Factor for Allogenic Transplantation Outcome for Hodgkin Lymphoma: a Retrospective Study From the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

Blood (2010) 116 (21): 2359.

https://doi.org/10.1182/blood.V116.21.2359.2359

Published: 2010

Journal Articles

High Intermittent Dose of Chlorambucil Associated with Rituximab Is a Promising Treatment of Elderly Patients with Indolent Lymphoma.

Laingo Andrianarison, Stephane Courby, Blandine Fabre, Lysiane Molina, Valerie Legrand, Brigitte Pegourie Bandelier, Audrey Simon, Clara Mariette, Claire Vettier, Christine Lefebvre, Frederic Garban, Claude Eric Bulabois, Anne Thiebaut, Jean Yves Cahn, Remy Gressin

Blood (2009) 114 (22): 4761.

https://doi.org/10.1182/blood.V114.22.4761.4761

Published: 2009

Journal Articles

Expression of the Chemokine Receptor CXCR4, CXCL12G801A Gene polymorphism and SDF1 Plasma Levels in B-Cell Chronic Lymphocytic Leukemia (B-CLL): Correlation with PBSC Mobilisation, Disease Characteristics and Outcome.

Adriana Plesa, MD, Gaetan Lesca, MD, Nathalie Dhedin, MD, Mohamad Sobh, Pharm.M, Anne S. Michallet, MD, PhD, Franck E. Nicolini, MD, PhD, Helene Merle-Beral, MD, PhD, Frederic Garban, MD, Veronique Leblond, MD, Karen Sagorny, Stephane Morisset, Alain Calender, MD, PhD, Charles Dumontet, MD, PhD, Michel Leporrier, MD, Laurent Sutton, MD, Mauricette Michallet, MD, PhD

Blood (2009) 114 (22): 2336.

https://doi.org/10.1182/blood.V114.22.2336.2336

Published: 2009

Journal Articles

The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire.

Andrea Toma, Marie-Lorraine Balère-Appert, Jean-Michel Boiron, MD, Pierre Bordigoni, Pr, Gerard Socie, MD, PhD, Jean-Paul Vernant, Pr, Marc Renaud, MD, Noel Milpied, MD, PhD, Mauricette Michallet, MD, PhD, Eric Deconinck, Pr, Denis Guyotat, MD, PhD, Frederic Garban, MD, Anne Sirvent, MD, Nathalie Contentin, MD, Didier Blaise, Pr, Evelyne Marry, Agnes Buzyn, Pr

Blood (2009) 114 (22): 873.

https://doi.org/10.1182/blood.V114.22.873.873

Published: 2009

Journal Articles

Safety and Efficacy of FLAMSA Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation From Related and Unrelated Donors in High Risk Acute Leukemia and MDS Patients: A Study From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry.

Blood (2009) 114 (22): 4335.

https://doi.org/10.1182/blood.V114.22.4335.4335

Published: 2009

Journal Articles

Long-Term Follow-up Results of IFM9903 and IFM9904 Trials Comparing Non Myeloablative Allotransplantation with Autologous Transplantation in High-Risk De Novo Multiple Myeloma.

Philippe Moreau, Frederic Garban, Michel Attal, MD, Mauricette Michallet, MD, PhD, Gerald Marit, Cyrille Hulin, Lotfi Benboubker, MD, Chantal Doyen, Mohamad Mohty, MD, PhD, Ibrahim Yakoub-Agha, MD, PhD, Serge Leyvraz, Philippe Casassus, MD, Hervé Avet-Loiseau, Laurent Garderet, Claire Mathiot, Jean-Luc Harousseau

Blood (2008) 112 (11): 1126.

https://doi.org/10.1182/blood.V112.11.1126.1126

Published: 2008

Journal Articles

Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC allo-SCT) for Patients with High-Risk Multiple Myeloma (MM): A Survey from the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire.

Mohamad Mohty, MD, PhD, Le Quoc-Hung, Franck E Nicolini, MD, PhD, Frederic Garban, MD, Gerard Socie, Michel Attal, MD, Noel- Jean Milpied, PhD, Bruno Lioure, MD, Pierre Bordigoni, MD, Ibrahim Yakoub-Agha, MD, PhD, Jean-Henri Bourhis, Bernard Rio, Eric Deconinck, Marc Renaud, MD, Jean-Luc Harousseau, Didier Blaise, MD, Mauricette Michallet, MD

Blood (2008) 112 (11): 2165.

https://doi.org/10.1182/blood.V112.11.2165.2165

Published: 2008

Journal Articles

Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma

Philippe Moreau, Frédéric Garban, Michel Attal, Mauricette Michallet, Gérald Marit, Cyrille Hulin, Lotfi Benboubker, Chantal Doyen, Mohamad Mohty, Ibrahim Yakoub-Agha, Serge Leyvraz, Philippe Casassus, Hervé Avet-Loiseau, Laurent Garderet, Claire Mathiot, Jean-Luc Harousseau

Blood (2008) 112 (9): 3914–3915.

https://doi.org/10.1182/blood-2008-07-168823

Published: 2008

Journal Articles

Impact of HLA Allele Mismatch on the Outcome of Patients with Reduced-Intensity Allogeneic Haematopoietic Stem Cell Transplantation from Unrelated Donors: Analysis of 103 Patients of the French Registry.

Andrea Toma, Marie-Lorraine Balere-Appert, Zina Chir, Jean-Michel Boiron, Pierre Bordigoni, Gerard Socie, Jean-Paul Vernant, Marc Renaud, Noel-Jean Milpied, Mauricette Michallet, Eric Deconninck, Denis Guyotat, Frederic Garban, Anne Sirvent, Nathalie Contentin, Didier Blaise, Colette Raffoux, Agnes Buzyn

Blood (2006) 108 (11): 3149.

https://doi.org/10.1182/blood.V108.11.3149.3149

Published: 2006

Journal Articles

Reduced-Intensity Conditioning (RIC) Regimen Followed by Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLCL). A Retrospective Study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) Registry.

Anne Sirvent, MD, Michael Hummelsberger, MD, Zina Chir, Nathalie Dhedin, MD, Catherine Faucher, MD, Jean-Pierre Jouet, MD, Michel Attal, MD, Patrice Chevalier, MD, Marie Robin, MD, Reza Tabrizi, MD, Pierre Bordigoni, MD, Jean-Henri Bourhis, MD, Agnes Buzyn, MD, Nathalie Contentin, MD, Jerome Cornillon, MD, Frederic Garban, MD, Mauricette Michallet, MD

Blood (2006) 108 (11): 2946.

https://doi.org/10.1182/blood.V108.11.2946.2946

Published: 2006

Journal Articles

Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma

Frederic Garban, Michel Attal, Mauricette Michallet, Cyrille Hulin, Jean H. Bourhis, Ibrahim Yakoub-Agha, Thierry Lamy, Gerald Marit, Frederic Maloisel, Christian Berthou, Mamoun Dib, Denis Caillot, Bernard dePrijck, Nicolas Ketterer, Jean-Luc Harousseau, Jean-Jacques Sotto, Philippe Moreau, for the Intergroupe Francophone du Myélome and the Swiss Group for Clinical Cancer Research

Blood (2006) 107 (9): 3474–3480.

https://doi.org/10.1182/blood-2005-09-3869

Published: 2006

Journal Articles

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly with Imatinib Mesylate (STI571) and Chemotherapy.

Blood (2005) 106 (11): 146.

https://doi.org/10.1182/blood.V106.11.146.146

Published: 2005

Journal Articles

Hierarchical Evaluation of Baseline Poor-Prognosis Factors and Response to Initial Therapy in Younger Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL) Treated in the Risk-Adapted GRAALL-2003 Study.

Francoise Huguet, Arnaud Pigneux, Eric Delabesse, Xavier Thomas, Kheira Beldjord, Martine Escoffre, Jean-Luc Harousseau, Oumedaly Reman, Frederic Garban, Agnes Buzyn, Marina Lafage, Yves Chalandon, Andre Delannoy, Jean-Paul Vernant, Veronique Lheritier, Marie-Christine Bene, Norbert Ifrah, Elizabeth MacIntyre, Herve Dombret

Blood (2005) 106 (11): 874.

https://doi.org/10.1182/blood.V106.11.874.874

Published: 2005

Journal Articles

Secondary or Concomitant Neoplasms among Adults Diagnosed with Acute Lymphoblastic Leukemia (ALL) and Treated According to the LALA-87 and LALA-94 Trials.

Blood (2005) 106 (11): 1826.

https://doi.org/10.1182/blood.V106.11.1826.1826

Published: 2005

NARROW

A Phase 2 Prospective Study Evaluating Low-Dose Deferasirox in Patients with Low-Risk Myelodysplastic Syndrome Resistant or Relapsing after Erythropoietin Stimulating Agents (LODEFI)

Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim

HLA-Matched Related Hematopoietic Stem Cell Transplantation in Adolescents and Adults with Sickle Cell Disease: Comparison of Myeloablative Versus Non Myeloablative Approaches. Report from the Société Francophone De Greffe De Moelle Et De Thérapie Cellulaire

Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS

Prophylactic Extracorporeal Photopheresis for Gvhd Prevention after Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation from Identical Siblings and 10/10 HLA Unrelated Hematopoietic Stem Cells Donors

Reduced Intensity Conditioning Regimens Do Not Offer a Survival Advantage to Myeloma Patients Receiving Allogeneic Stem Cell Hematopoietic Transplantation: A Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry Study,

Disease Status Is the Major Prognosis Factor for Allogenic Transplantation Outcome for Hodgkin Lymphoma: a Retrospective Study From the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

High Intermittent Dose of Chlorambucil Associated with Rituximab Is a Promising Treatment of Elderly Patients with Indolent Lymphoma.

Expression of the Chemokine Receptor CXCR4, CXCL12G801A Gene polymorphism and SDF1 Plasma Levels in B-Cell Chronic Lymphocytic Leukemia (B-CLL): Correlation with PBSC Mobilisation, Disease Characteristics and Outcome.

The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire.

Safety and Efficacy of FLAMSA Regimen Followed by Allogeneic Hematopoietic Stem Cell Transplantation From Related and Unrelated Donors in High Risk Acute Leukemia and MDS Patients: A Study From the Societe Française De Greffe De Moelle Et De Therapie Cellulaire (SFGM-TC) Registry.

Long-Term Follow-up Results of IFM9903 and IFM9904 Trials Comparing Non Myeloablative Allotransplantation with Autologous Transplantation in High-Risk De Novo Multiple Myeloma.

Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation (RIC allo-SCT) for Patients with High-Risk Multiple Myeloma (MM): A Survey from the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire.

Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma

Impact of HLA Allele Mismatch on the Outcome of Patients with Reduced-Intensity Allogeneic Haematopoietic Stem Cell Transplantation from Unrelated Donors: Analysis of 103 Patients of the French Registry.

Reduced-Intensity Conditioning (RIC) Regimen Followed by Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLCL). A Retrospective Study from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) Registry.

Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly with Imatinib Mesylate (STI571) and Chemotherapy.

Hierarchical Evaluation of Baseline Poor-Prognosis Factors and Response to Initial Therapy in Younger Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL) Treated in the Risk-Adapted GRAALL-2003 Study.

Secondary or Concomitant Neoplasms among Adults Diagnosed with Acute Lymphoblastic Leukemia (ALL) and Treated According to the LALA-87 and LALA-94 Trials.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only